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Brief CommunicationPhotocontrol of Cell Adhesion
Processes: Model Studies with
Cyclic Azobenzene-RGD Peptides
exploited a backbone-incorporated azobenzene moiety
for reversible cis/trans photoisomerization of the confor-
mational states of constrained cyclic peptides [18–21].
In the present study, this concept was applied for the
design of integrin ligands, and with the cyclic azoben-
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Am Klopferspitz 18A zene peptide c[-Lys1-Ala2-Arg3-Gly4-Asp5-D-Phe6-Val7-
AMPB-] (1), photomodulation of binding affinity for v382152 Martinsried
Germany integrin was successful.
Results and DiscussionSummary
Based on our previous experiences with (4-amino)phe-A photoresponsive integrin ligand was synthesized by
nylazobenzoic acid and (4-aminomethyl)phenylazoben-backbone-cyclization of a heptapeptide containing the
zoic acid (AMPB) as cyclic peptide-backbone constit-integrin binding motif Arg-Gly-Asp (RGD) with 4-(amino-
uents [22], modeling experiments were suggesting thatmethyl)phenylazobenzoic acid (AMPB). Surface plas-
cyclization of hexapeptides containing the RGD motifmon enhanced fluorescence spectroscopy showed
in permutated sequence positions should be feasible,that binding of the azobenzene peptide to v3 integrin at least when using the more flexible AMPB derivative.depends on the photoisomeric state of the peptide
The sequence of the hexapeptide was adapted to thechromophore. The higher affinity of the trans isomer
well-known v3 integrin ligand c[-Arg-Gly-Asp-D-Phe-could be rationalized by comparing the NMR confor-
Val-] [23, 24] by adding a lysine residue for possiblemations of the cis and trans isomers with the recently
side-chain labeling. However, all synthetic efforts failedsolved X-ray structure of a cyclic RGD-pentapeptide
even when applying different cyclization sites and mac-bound to integrin.
rolactamization procedures. By expanding the ring size
with an additional amino acid residue, cyclization of the
Introduction side-chain-protected H-Asp(OtBu)-D-Phe-Val-AMPB-
Lys(Boc)-Ala-Arg(Boc)2-Gly-OH with PyBOP/HOBt was
Cell adhesion is a crucial process in the assembly of successful, and upon deprotection with TFA/H2O (95:5)
individual cells into the three-dimensional architecture the target peptide 1 was obtained as an analytically well-
of animal tissues [1]. Although stable cell interactions characterized compound.
are required for the structural integrity of tissues, active Cis/trans photoisomerization of the cyclic peptide 1
adhesion mechanisms are essential for the proper func- in aqueous solution by irradiation at 360 and 450 nm,
tionality of many physiological processes such as em- respectively, is a fully reversible process (trans isomer,
bryogenesis, cell differentiation, haemostasis, wound max  335.5 nm; cis isomer, max  253.4 nm). After
healing, and immune responses, but also for pathophys- relaxation at 50C in the dark, 1H-NMR spectra were
iological events such as tumor cell extravasation or inva- consistent with the presence of almost exclusively trans-
sion [2–4]. These cell adhesion processes are mediated azobenzene isomer (99%), whereas upon irradiation
by cell-surface receptors, among which integrins repre- at 360 nm a maximum content of 80% of cis isomer
sent the most diverse and prominent family [5–7]. As a could be obtained in the photostationary state, as de-
main integrin-ligand motif, the tripeptide sequence Arg- rived from the NMR spectra. This fully agrees with previ-
Gly-Asp (RGD) has been identified; it is found in most ous results from cyclic azobenzene peptides [18–21].
of the matrix proteins [1, 8, 9], and selectivity of these The NMR spectra of the two isomers are characterized
molecular recognition processes is dictated by addi- by distinct sets of resonances. These differ in the chemi-
tional ligand epitopes. Moreover, conformational fea- cal shifts to extents that allow unambiguous assignment
tures, i.e., differentiated spatial displays, of the RGD even for the cis isomer in the photostationary state.
motif are decisive for both affinity and selectivity as- From the NOESY spectra, sufficient interproton distance
sessed with conformationally restricted cyclic RGD pep- constraints could be extracted to define the structural
tides [10–12]. This marked conformation-dependent preferences of the two isomers in aqueous solution. The
binding affinity of RGD ligands for integrins lends itself smaller ring size of the RGD peptide compared to the
to a photocontrol of this molecular recognition process cyclic azobenzene peptides of our previous studies re-
by the use of suitable photoresponsive RGD constructs. sults in a highly frustrated system for the trans-azoben-
Azobenzene has been extensively used in the past as zene isomer which flip-flops between conformational
a versatile light switch for reversible photomodulation of substates with two different orientations of the azoben-
a wide spectrum of physical and biophysical properties zene moiety and the peptide portion Lys1-Ala2-Arg3-Gly4.
[13,14] including conformational states of model pep- These substates are linked by independent hinge mo-
tides [15–17]. In previous studies, we have successfully tions (around Val7/Lys1 and Lys1/Gly4) (Figure 1). Photo-
isomerization to the cis-isomer relaxes the system into
a larger conformational space occupied by an ensemble*Correspondence: moroder@biochem.mpg.de
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azobenzene peptide 1 was fluorescence labeled with
Cy5 at the side-chain amino group of the Lys residue.
The binding affinities of the cyclic peptide 1 in the trans
and cis conformation were assayed with this experimen-
tal set-up. As shown in Figure 2, the cis isomer was
found to exhibit a significantly lower binding affinity than
its trans isomer (40% 10%). Selective binding of the
ligand to the integrin was assessed by its reversal with
EDTA, since Mn2	 is an essential proadhesive cation. A
similarly Cy5-labeled derivative of the well-established
v3 integrin ligand c[-Asp-D-Phe-Val-Lys-Arg-Gly-] [32]
was used as positive control. In this system, it exhibits
a binding affinity of the same order of magnitude,
whereas no fluorescence was detected with the Cy5-
labeled cyclic azobenzene peptide c[Lys-AMPB-Lys-
Cys-Ala-Thr-Cys-Asp-Lys-Lys] that lacks the RGD motif
as negative control. In situ photoisomerization of the
integrin ligand peptide is hampered by adverse interfer-
ences of the Cy5 dye.
Initial modeling studies based on the known structural
preferences of v3 integrin ligands [11] predicted an
easier fit of the cis conformer into the integrin binding
pocket. However, the experimental findings clearly re-
vealed higher binding affinity of the trans isomer with
its peptide chain in a rather stretched parallel alignment
to the azobenzene moiety. To rationalize this observa-
tion, the coordinates of the crystal structure of the extra-
cellular portion ofv3 integrin complexed with the cyclic
pentapeptide c[-Arg-Gly-Asp-D-Phe-(Me)Val-] (Protein
Data Bank entry 1L5G) [27] were used to match the
ligand conformations (Figure 3). Although not in optimal
mode, the RGD portion of the cyclic trans-azobenzene
peptide displays the essential Asp and Arg side chains
in a similar mode for interaction with the protein binding
pocket. However, the chain reversal at the D-Phe-Val
sequence portion as imposed by the trans azobenzene
conformation would clash with a protein loop unless
some flexibility in the peptide or the protein counterpart
allows for better adaptation of this ligand. On the other
hand, the entropic cost for binding of the cis isomer
with its larger conformational space is unfavorable and
may thus account for the weaker binding already re-
ported for conformationally nonrestricted RGD peptidesFigure 1. NMR Structural Ensembles for Both Isomers of the Azo-
[10–12].benzene Peptide 1
Stick models of the ten lowest energy structures of c[-Asp-D-Phe-
Val-AMPB-Lys-Ala-Arg-Gly-] in the trans (A) and cis conformation
Significance(B). The peptide backbone is colored gray, the AMPB moiety is
orange, and the Arg and Asp side chains are in atom colors.
The experimental results have validated the concept
of conformationally restricted azobenzene peptides
containing the ubiquitous RGD integrin binding motifof structures that differ significantly in the peptide-back-
bone fold and, correspondingly, even in the spatial dis- for photomodulation of adhesion processes. With the
structural information now available from the crystal-play of the RGD side chains.
We have recently developed a peptide-tethered artifi- lographic analysis of thev3 integrin/cyclic RGD-pep-
tide complex and the NMR conformational analysis ofcial lipid membrane system with functionally incorpo-
rated integrins that allows monitoring of integrin-ligand the cyclic azobenzene peptide, amelioration of binding
affinities can be envisaged by modification of the se-interactions by surface plasmon enhanced fluorescence
spectroscopy (SPFS) [25]. This system proved well quence composition as well as extension of the ring
size. Similarly, changes in the experimental set-up ofsuited for analyzing differentiated binding affinities of
synthetic heterotrimeric collagen peptides containing the surface plasmon spectroscopy may allow bypass
of the use of interfering fluorescent dyes and thus inthe 11 integrin binding epitope of collagen type IV [26].
For the purposes of the present study, v3 integrin was situ photomodulation of the integrin binding affinities,
with the ultimate goal of a photocontrol of cell adhe-incorporated into the artificial lipid membrane, and the
Photoresponsive Integrin Ligands
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Figure 2. Integrin Binding of Azobenzene
Peptide 1
A representative experiment is shown for the
SPFS binding assay of fluorescence-labeled
peptide 1 using an artificial v3 integrin mem-
brane preparation coated on a gold surface.
Background signals are subtracted from the
fluorescence scans. The fluorescence scans
corresponding to the integrin with bound
peptide 1 as cis (black circles) and trans iso-
mer (gray circles) are shown; likewise, the
plasmon scans upon binding of cis (black tri-
angles) and trans isomer (gray triangles) are
reported. In the fluorescence scan of the
bound trans isomer, an artifact due to internal
reflections is present between 46 and 47
angles of incidence.
1D spectra. Structure calculations and evaluations were performedsion for time-resolved monitoring of associated cellu-
with the INSIGHTII 2000 software package (Accelrys, San Diego) aslar processes.
described previously [19]. No significant violations of experimental
constraints occurred for any of the calculated structures.Experimental Procedures
Synthesis SPFS Measurements
Details of the synthesis of the cyclic RGD peptide with AMPB as SPFS binding experiments were carried out using a self-assembled
backbone constituent and its analytical and spectroscopic charac- set-up with v3 integrin (Chemicon Inc., Temecula, Ca) embedded
terization will be reported elsewhere. into a DMPE/PC bilayer coated to the gold surface via a hydrophilic
laminin-peptide layer as described elsewhere [25]. The cyclic
NMR Conformational Analysis azobenzene-peptide 1 and c[-Asp-D-Phe-Val-Lys-Arg-Gly-] [32] as
NMR spectra of the azobenzene peptide were recorded in water well as the oxidized c[Lys-AMPB-Lys-Cys-Ala-Thr-Cys-Asp-Lys-
and at 303 K on a Bruker DRX 500 spectrometer equipped with Lys] (unpublished synthesis) were fluorescence labeled with Cy5
pulsed-field-gradient (PFG) accessories at a proton frequency of N-hydroxysuccinimide ester (Amersham Pharmacia, Uppsala, Swe-
500.13 MHz. Resonance assignments were performed according to den) via acylation of the Lys side-chain amino group, and quantita-
the method of Wu¨thrich [28]. The 2D TOCSY was recorded with a tive derivatization was assessed by hplc. The fluorescence experi-
spin-lock period of 75 ms using the MLEV-17 sequence for isotropic ments were performed after incubation of the peptides at room
mixing [29]. Experimental distance constraints (trans isomer, 44; cis temperature in 50 mM Tris•HCl (pH 7.4), 150 mM NaCl, 2 mM
isomer, 56) were extracted from 2D ROESY [30] experiments with MgCl2•6H2O, and 10 mM MnCl2•2H2O for 30 min followed by rinsing
a mixing time of 100 ms. Angle constraints (trans isomer, 5; cis with the buffer. Complex dissociation was achieved by incubation
isomer, 6) were extracted from 2D DQF-COSY [31] and simple 1H- with 0.5 M EDTA. The reported difference in binding affinity between
cis and trans isomer is the average of four independent measure-
ments. Repetitive measurements on the same membrane prepara-
tion are possible, but due to aging/deterioration effects we preferred
fresh membrane preparation for each experiment.
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